Barely Significant
← all excerpts

New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel.

Clin Cosmet Investig Dermatol · 2012 · PMC3430094 · PMID 22956883

1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP < 0.001actually significant
57 Results for the primary endpoint of complete clearance were also highly significant, favoring ingenol mebutate in each of the four individual studies ( P < 0.001). 57 The efficacy of ingenol mebutate varied according to anatomic location, with higher rates of complete clearance associated with facial AK (ingenol mebutate versus vehicle, 47.3% versus 4.1%; P < 0.001) than with scal

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.